New Delhi:Admittingthat the antimicrobial resistance (AMR) burden in India is among the highest in the world, the Indian Journal of Medical Research (IJMR) has said thathealthcare-acquired infections (HAIs) and lack of awareness about it lead to AMR which is one of the top global public health and development threats.
“One of the significant contributors of AMR burden in India is healthcare-acquired infections. Healthcare facilities are often the starting point or multiplier for AMR infections, which can contribute to further transmission in the community locally and internationally," the open journal of IJMR said in its latest issue.
The research paper further stated that the high prevalence of AMR in HAIs warrants the need to better understand the drivers of AMR in Indian hospitals.
“However, there is a paucity of knowledge on factors contributing to AMR in HAIs in Indian hospitals; as a result, the optimal prevention measures needed to inform interventions to counteract AMR are mostly unknown," it said
Although country-wide HAI rates are not available, an earlier study in intensive care units (ICUs) in 40 Indian hospitals found pooled device-associated HAI rates to be substantially higher than the United States Centers for Disease Control and Prevention's (CDC) National Healthcare Safety Network median rates, despite Indian ICUs having lower device utilisation ratios.
Central line-associated bloodstream infection (CLABSI) rates in Indian ICUs were reportedly at least five times higher than rates in the United States ICUs, the findings said.
Antimicrobial resistance is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.
Dr Tamorish Kole, past president of the Asian Society for Emergency Medicine told ETV Bharat that patients should stop using antibiotics on their own as this has become a common practice in India.
"Acknowledging the same, India's National Action Plan (NAP) to combat Antimicrobial Resistance (AMR) was unveiled in April 2017 by the Union Ministry of Health and Family Welfare. The NAP outlines a comprehensive strategy to address AMR, focusing on several key objectives like enhancing awareness, strengthening surveillance, infection prevention and control, research and development and collaborative activities," said Dr Kole.
What WHO says?
According to the World Health Organisation (WHO), antimicrobial resistance occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death.